Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

37 API Suppliers, 15 USDMF, 5 CEP/COS, 3 JDMF, 6 EU WC, 2 KDMF, 19 NDC API, 22 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

124 Drugs in Development

124 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

141 FDF Dossiers, 9 FDA Orange Book, 101 Europe, 7 Canada, 12 Australia, 7 South Africa, 5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INHALATION - 0.05MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.2MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.05MG/INH, POWDER;INHALATION - 0.1MG/INH, POWDER;INHALATION - 0.2MG/INH, SPRAY, METERED;NASAL - 0.0275MG/SPRAY

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 2 DKSH, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 4 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 BASF, 4 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures, 10 Kerry, 2 Keval Exports, 1 Kima Chemical, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 7 Roquette, 6 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 Silverline Chemicals, 1 The Dow Chemical Company, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Fillers, Diluents & Binders, 19 Thickeners and Stabilizers, 15 Solubilizers, 13 Direct Compression, 11 Granulation, 10 Parenteral, 9 Co-Processed Excipients, 9 Lubricants & Glidants, 6 Rheology Modifiers, 5 Disintegrants & Superdisintegrants, 4 Film Formers & Plasticizers, 4 Emulsifying Agents, 4 Coating Systems & Additives, 3 Surfactant & Foaming Agents, 3 Topical, 3 Controlled & Modified Release, 3 Chewable & Orodispersible Aids, 2 Taste Masking, 1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 54 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 56 Regulatory FDF Prices, 42 Annual Reports

MARKET PLACE

6 APIs

6 APIs

PATENTS & EXCLUSIVITIES

73 US Patents, 5 US Exclusivities, 19 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP

4 USP

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
31/10/2025	Coral Drugs Private Limited	India	CORAL DRUGS PRIVATE LTD	32040	FLUTICASONE FUROATE	2017-10-02	Active	II	N/A
31/10/2025	Vamsi Labs	India	VAMSI LABS LTD	40418	FLUTICASONE FUROATE EP	2024-08-26	Active	II	N/A

[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] Furan-2-carboxylate

[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

37 API Suppliers

15 USDMF

5 CEP/COS

3 JDMF

6 EU WC

2 KDMF

19 NDC API

22 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

124 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

141 FDF Dossiers

9 FDA Orange Book

101 Europe

7 Canada

12 Australia

7 South Africa

5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INHALATION - 0.05MG/INH;EQ 0.025MG BASE/INH

POWDER;INHALATION - 0.1MG/INH;EQ 0.025MG BASE/INH

POWDER;INHALATION - 0.2MG/INH;EQ 0.025MG BASE/INH

POWDER;INHALATION - 0.05MG/INH

POWDER;INHALATION - 0.1MG/INH

POWDER;INHALATION - 0.2MG/INH

SPRAY, METERED;NASAL - 0.0275MG/SPRAY

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 SPI Pharma

2 DKSH

3 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

3 Kirsch Pharma

4 Actylis

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

1 BASF

4 DFE Pharma

1 Finar

6 Gangwal Chemicals

1 Ideal Cures

10 Kerry

2 Keval Exports

1 Kima Chemical

12 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

1 Pharmatrans-Sanaq

2 Pluviaendo

2 Prachin Chemical

7 Roquette

6 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

8 Sigachi Industries

2 Silverline Chemicals

1 The Dow Chemical Company

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Fillers, Diluents & Binders

19 Thickeners and Stabilizers

15 Solubilizers

13 Direct Compression

11 Granulation

10 Parenteral

9 Co-Processed Excipients

9 Lubricants & Glidants

6 Rheology Modifiers

5 Disintegrants & Superdisintegrants

4 Film Formers & Plasticizers

4 Emulsifying Agents